May 27, 2018

The New Federal Blueprint to Lower Drug Prices

Written by

On Friday, May 11, 2018, President Trump vowed to fix “the injustice of high drug prices” by announcing the “Blueprint to Lower Drug Prices” (the Blueprint) to address the following challenges:

  1. Excessively high drug prices
  2. Seniors and government programs overpaying for drugs
  3. High out-of-pocket costs for consumers
  4. Lack of transparency in drug pricing
  5. Free-riding by foreign nations as to US investment in innovation

This piece provides analysis of the Blueprint and its proposed reforms.  Read PDF.

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *